Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00015830
DRKS00015830
Completed
Phase 4

Prospective, single-center, interventional follow-up study to determine the effect of prostate carcinoma and its operative therapy on intraocular pressure and determination of potential mediators.

Diakonie Klinikum Dietrich Bonhoeffer GmbH0 sites76 target enrollmentFebruary 11, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsprostate cancer, mamma carcinoma, colorectal carcinomaH40.1Primary open-angle glaucoma

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
prostate cancer, mamma carcinoma, colorectal carcinoma
Sponsor
Diakonie Klinikum Dietrich Bonhoeffer GmbH
Enrollment
76
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 11, 2019
End Date
June 30, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •For the test group with prostate cancer
  • •1\. Patients with prostate cancer (all stages) on whom a radical prostatectomy is planned in Neubrandenburg
  • •2\. Willingness of patients to participate in the study with an informed written consent
  • •For the comparison group
  • •1\. Patient of the eye clinic, male sex
  • •2\. no history of prostate cancer known
  • •3\. PSA value \=4\.5 ng / ml
  • •4\.Willingness of patients to participate in the study with written consent
  • •For the test group with breast cancer
  • •1\. Patients with breast cancer (all stages)

Exclusion Criteria

  • •For all test groups
  • •1\. Glaucoma (anamnesis and HRT examination)
  • •2\. Other eye disease that interferes with an IOP measurement or examination of the anterior segment of the eye
  • •3\. Malignant disease other than prostate cancer, breast cancer and colon cancer (currently or within the last 15 years)
  • •4\. Rheumatologic or autoimmune disease
  • •5\. Allergy to eye drops with local anesthetics, fluorescein and preservatives
  • •For the comparison group
  • •1\. Glaucoma (anamnesis and HRT examination)
  • •2\. Other eye disease that interferes with IOP measurement or examination of the anterior segment of the eye
  • •3\. Malignant disease (current or within the last 15 years)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
An interventional study to assess the effect of spiritual therapy in the treatment of autistic childreHealth Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders
CTRI/2022/06/043459Bhaktivedanta Hospital and Research Institute
Completed
Not Applicable
A Clinical study to compare the Efficacy & Safety of Instavit instant energy oral spray for the fatigue conditio
CTRI/2018/01/011170Instavit Ltd50
Completed
Not Applicable
Single Center Prospective Controlled Follow-up Study of COVID-19 Patients District Konstanz (FSC19-KN)COVID 19
DRKS00022409Hegau-Bodensee-Klinikum Singen526
Recruiting
Not Applicable
on-interventional, prospective, multicenter study to evaluate treatment satisfaction, treatment preference, quality of life, and tolerability under treatment with Briumvi® for relapsing forms of multiple sclerosis (RMS) with active disease in daily clinical practiceG35Multiple sclerosis
DRKS00034406euraxpharm Pharmaceuticals, S.L.600
Recruiting
Not Applicable
A prospective, multicenter, single-arm follow-up study to systematically record motor symptoms and associated quality of life in idiopathic Parkinson's patientsG20Parkinson disease
DRKS00032799EVER Pharma GmbH100